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ABSTRACT  
High fat diets are commonly used in aquaculture to reduce feed cost in Nile tilapia, 
but impair its lipid homeostasis. This study evaluated the role of forskolin on 
reducing fat accumulation in Nile tilapia (Oreochromis niloticus) by using in vitro 
and in vivo experiments. The use of 50 μM forskolin in vitro increased free fatty 
acid and glycerol release, but decreased triglyceride in adipocytes and hepatocytes. 
The adipose triglyceride lipase (ATGL), protein kinase cAMP-dependent type I 
regulatory subunit alpha (PKAR I) and other genes related to β-oxidation 
(peroxisome proliferator activated receptor alpha, PPARα and carnitine 
O-palmitoyltransferase 1, CPT1) were significantly up-regulated. After feeding a 
high-fat diet for six weeks, O. niloticus were fed with 0 (control), 0.5 and 1.5 mg/kg 
forskolin for two weeks to determine whether forskolin could reduce fat 
accumulation in vivo. Fish fed the two levels of forskolin decreased significantly 
the hepatosomatic and mesenteric fat indices. The total lipid in the whole fish and 
liver together with the serum glycerol content were lower in fish fed on forskolin 
than in the control. The fish fed on forskolin diets exhibited smaller areas of lipid 
droplets in adipose and liver tissues. Lipolysis related genes (ATGL, 
hormone-sensitive lipase, HSL; monoacylglycerol lipase, MGL; and protein kinase 
cAMP-activated catalytic subunit, PKAC) and β-oxidation genes (PPARα; fatty 
acid binding protein 1, FABP1; and CPT1) in the adipose were up-regulated. 
Similarly, in the liver lipolysis genes such as ATGL and PKAR I and β-oxidation 
genes (PPARα, FABP1, C T1 and acyl-CoA oxidase, ACO) showed an increasing 
trend with the increase of forskolin doses. This study indicates that forskolin can 
reduce fat accumulation in the adipose and liver by stimulating lipolysis and 
β-oxidation in O. niloticus.  
Keywords: Oreochromis niloticus, forskolin, lipolysis, β-oxidation 
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1. Introduction 
Dietary fats play an important role in fish nutrition by providing essential fatty 
acid and energy. The lipid-rich diets are used widely because of their 
protein-sparing effects (Beamish and Medland, 1986; Watanabe, 1982). However, 
this practice increases fat deposition in cultured fish, compromises fish health, alters 
metabolic patterns (Lauriano et al., 2016; Rueda-Jasso et al., 2004) and lowers 
growth and feed efficiency (Du et al., 2006; Nath et al., 2018). Therefore, it is 
crucial to develop effective feeding strategies to reduce fat accumulation in cultured 
fish.  
Different approaches including pharmacologic therapy, surgery and dietary 
supplements have been used as treatments to reduce overweight and obesity in 
humans (Colker et al., 1999; Van and F., 2008; Yamoneka et al., 2015). Dietary 
supplements offer several advantages over traditional therapy such as low toxic 
profile, easy accessibility to the general population and wide availability because 
they are sold over-the-counters (Ríos-Hoyo and Gutiérrez-Salmeán, 2016). Previous 
studies have investigated the effects of some dietary supplements that are derived 
from plants on reducing obesity by using in vitro and in vivo methods in various 
species (Hu et al., 2012; Oben et al., 2008; Park, 2015). African wild mango 
(Irvingia gabonensis) inhibited adipogenesis in adipocytes by down-regulating the 
adipogenic transcription factor (peroxisome proliferator-activated receptor gamma 
(PPAR-γ) (Oben et al., 2008). Raspberry ketone inhibited adipogenesis, adipocyte 
differentiation and increased transcriptional activities of genes involved in lipolysis 
and oxidation (Park, 2015). Fucoxanthin, a carotenoid present in edible brown 
seaweeds, exerted anti-obesity effects by regulating mRNA expression of enzymes 
related to lipid metabolism in white adipose tissue in diet-induced obesity rats (Hu 
et al., 2012). A few dietary supplements are also used in aquaculture to modulate 
lipid metabolism in fish. For example, silibinin from Silybum marianum inhibited 
lipid accumulation in zebrafish (Suh et al., 2015) and grass carp (Xiao et al., 2017) 
by reducing adipogenic factors and triglyceride levels. Although these ingredients 
have effects within preclinical or small-scaled clinical trials, the majority of these 
trials do not show health-related evidences, food-drug interactions and dose-related 
body fat reductions (Ríos-Hoyo and Gutiérrez-Salmeán, 2016). 
Forskolin is a labdane diterpene produced from the root of Coleus forskohlii 
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(Bhat et al., 1977). Its extract has been recorded in Ayurveda medicine since ancient 
times and its medicinal value has been studied since early-1980s (Bristow et al., 
1984; Kavitha et al., 2010). Early studies have suggested that forskolin is a potential 
agent for management and treatment of obesity. Forskolin promoted lipolysis by 
regulating the production of cyclic adenosine monophosphate levels in membranes, 
cells, or tissues (Insel and Ostrom, 2003) through activation of cAMP-dependent 
protein kinase (PKA) and hormone-sensitive lipase (HSL) (Belfrage et al., 1982). 
Previous studies have also shown that, forskolin regulates lipolysis by stimulating 
perilipin A in mice adipocytes (Miyoshi et al., 2006) and adipose triglyceride lipase 
(ATGL) in human multipotent adipose-derived stem (hMADS) cells (Bezaire et al., 
2009). In small-scaled clinical trials, the in vivo use of forskolin supplements for 12 
weeks twice a day decreased significantly the body fat in obese men (Godard et al., 
2005). Its supplement has also been shown to increase significantly the high-density 
lipoprotein-cholesterol together with reduction of waist and hip circumference in 
humans (Loftus et al., 2015). However, compared to the knowledge on the use of 
forskolin for regulation of lipolysis in mammals, information on its effects in fish is 
currently unknown. Considering the potential effect of forskolin on reducing fat 
accumulation, there is a need for further exploration on its physiological role in fat 
reduction and the underlying mechanisms in cultured fish. 
Nile tilapia (Oreochromis niloticus) is an important species farmed worldwide 
(Doan et al., 2018). Lipid-rich diets are commonly used in Nile tilapia aquaculture 
to reduce feed cost, but impair lipid homeostasis (Huang et al., 2016). Therefore, it 
is important to determine whether forskolin can stimulate lipolysis and reduce fat 
accumulation in cultured fish where high lipid deposition is undesired. Currently, no 
research has been conducted to investigate the potential role of forskolin on 
lipolysis in cultured fish species such as Nile tilapia. The primary objectives of this 
study were to determine whether 1) forskolin in vitro stimulates lipolysis on Nile 
tilapia adipocytes (APCs) and hepatocytes (HPCs) and its associated mechanisms; 
and 2) forskolin (0.5 mg/kg BW and 1.5 mg/kg BW) in vivo has a positive effect on 
the reduction of fat accumulation in Nile tilapia fed on high fat diet.  
 
2. Materials and methods 
2.1. Ethical statement  
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This research was approved by the Animal Ethics Committee of East China 
Normal University and all experiments were conducted according to the protocols 
and procedures of the Laboratory Animal Management Ordinance of China. 
 
2.2. In vitro experimental designs 
2.2.1. Fish source, isolation of adipocytes and hepatocytes 
Four Nile tilapia (above 500 g) were purchased from Yueqiang Company 
(Guangzhou, China). Animals were anesthetized with MS-222 (25 mg/L) and then 
killed by a lethal blow on the head, followed by immersion in 75% ethanol for 30 s. 
The APCs and HPCs were isolated as described previously by Albalat et al. (2005) 
with some modifications. Individual fat or liver tissues from the four fish were 
pooled and cut into thin pieces. Tissues were incubated in a shaking water bath at 
28 
°
C for 60 min with the Dulbecco's Modified Eagle's medium (DMEM, Thermo 
Fisher, China) buffer containing collagenase type II and IV for the fat and liver 
tissue, respectively. The cell suspension was filtered through a nylon strainer and 
then washed three times by using the Krebs–Hepes buffer containing 1% bovine 
serum albumin (BSA). Cells were centrifuged at 1000 rpm for 10 min and 
resuspended with the DMEM buffer containing 10% fetal bovine serum (FBS). 
Cells were incubated in a petri dish at 28 
°
C with 5% CO2 overnight and then 
washed three times by using phosphate-buffered saline (PBS). Finally, cells were 
carefully resuspended at approximately 10
6
 cells / mL with FBS free DMEM and 
incubated for 1 h in a 12-cell dish at 28 
°
C containing 0 (control), 50, 100 µM 
forskolin (APExBIO, USA) in four replicates in order to establish the effective dose. 
Both forskolin doses stimulated HPCs lipolysis and increased free fatty acids (FFAs) 
release while only 50 μM was effective in APCs (Fig. 1S). Based on this 
preliminary experiment, 50 µM forskolin was chosen as the dose for further 
experiments, thereafter cells were incubated at 0 (control) and 50 µM forskolin.  
 
2.2.2. Free fatty acids (FFAs) and glycerol analysis  
At the end of incubation period with forskolin, cells were centrifuged at 1000 
rpm for 10 min at 4 
°
C. Cell-free aliquots of the media were taken to measure the 
concentrations of FFAs and glycerol as an index of lipolysis using commercial kits 
(Jiancheng Biotech CO., China). The remaining medium was removed and 1-mL 
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Trizol reagent or 1-mL chloroform/methanol (1:1, v/v) was added for transcriptomic 
analysis by using quantitative PCR (RT-PCR) and measurement of TG 
concentration in cells by thin-layer chromatography (TLC). 
 
2.2.3. Lipolysis and β-oxidation transcriptomic analysis  
The total RNA was extracted to measure the expression of ATGL, HSL, PKA, 
peroxisome proliferator-activated receptor alfa (PPAR), fatty acid-binding protein 
1 (FABP1) and carnitine palmitoyltransferase 1 (CPT1) genes. Total RNA extraction 
was carried out using Trizol reagent (RN0101, Aidlab, China). The RNA quantity 
and quality were checked on a Nano Drop 2000 spectrophotometer (Thermo, 
Wilmington, USA). Total RNA (1000 ng) was reversely transcribed using a 
PrimeScript
TM
 RT Master mix (RR047A, Takra, Japan) at 42 
°
C for 2 min to remove 
genomic DNA and at 37 
°
C for 15 min and 85 
°
C for 5 sec to complete reverse 
transcription. The cDNA was unified according to the measured concentration 
before quantitative PCR (RT-PCR). The RT-PCR amplification (in duplicate) was 
performed using 2  ultra SYBR mixture (CW0957, Kangwei, China). The 
elongation factor 1-alpha (EF1) was used as the internal reference gene.  
The PCR samples were prepared in a final volume of 20 μL consisting of 10 
μL of 2  ultra SYBR mixture, 0.5 μL of 10 mM forward and reverse primers, 2 μL 
of cDNA template and 7 μL of H2O with following cycling conditions: initial 
denaturation at 95 
°
C for 30 sec, followed by 40 cycles of 94 
°
C for 15 sec and 72 
°
C 
conducted in the CFX96 Real-time PCR system (Bio-rad, Richmond, CA). The 
cycle time (Carmen and Víctor) values of different treatments were compared to 
their corresponding internal control and then converted to fold change values by 
comparing the control group (without forskolin). All the primers for the 
amplification of genes used in this study are listed in Table 1.  
 
2.2.4. Triglyceride content analysis 
The TG content was quantified as described previously by Blank et al. (1964) 
and Skipski et al. (1964) with some modifications. Briefly, the total lipid obtained in 
section 2.2.2. above were separated by TLC using heptane/ether/acetic acid (55:45:1 
by volume). Plates were heated in an oven for 20 min at 60 
°
C to remove the 
adsorbents. Different doses of TG standards 2, 4 and 6 μg (ZZStandard, China) were 
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applied carefully to the plates with 5 μL standardized micropipettes. The plates were 
developed in the iodine chambers and analyzed for TG content by using thin-layer 
chromatogram scanner (KH-3000, kEZHE, Shanghai). Peak area of TG standard 
was calculated from a standard curve. The TG content was quantified by using a 
standard curve. 
 
2.3. In vivo experimental designs  
2.3.1. Experimental fish and feeding management procedures  
About 350 Nile tilapia were purchased from Yueqiang Company (Guangzhou, 
China). They were acclimated in one (500 L) tank for 10 days. Fish were supplied 
with compressed air via air-stones from air pumps at a 10 h/14 h light/dark cycle and 
water quality parameters were maintained at optimal levels for Nile tilapia growth 
and survival. During this period, the fish were hand-fed using a commercial diet 
(Chengdu, China) containing > 33% protein and > 5% lipid. After 10 days of 
acclimation 35 fish (weight 4.41 ± 0.32 g) were randomly distributed into nine 300 
L tanks. To determine whether forskolin had a positive effect on reducing fat 
accumulation on Nile tilapia, fish were first fed with a high fat diet (Table 2, total 
lipid 15.31%) to accumulate body fat for six weeks. During the first six weeks, all 
fish were fed thrice daily (at 0800, 1200 and 1700 h) at a feeding rate of 5% body 
weight using the high fat diet. Two hours after each feeding occasion, the uneaten 
diets were removed by siphon, dried and weighed for determination of feed 
conversion ratio (FCR). 
On the first day of the 7
th
 week, all fish (weight 11.57 ± 1.81 g) were 
redistributed randomly into three groups: control (0), medium forskolin (0.5 mg/kg) 
and high forskolin (1.5 mg/kg) each group containing 35 fish/tank in triplicate. The 
forskolin diet was prepared by dissolving forskolin in dimethyl sulphoxide (DMSO) 
(Table 2). The resulting forskolin solution was mixed with a given amount of wheat 
flour to make a wet dough. Wet dough was made by hand into small pellets of 
approximately 1.5 mm based on size of the fish. When fish ingested the forskolin 
particles at 1% body weight, the amount of forskolin consumed was equivalent to 
0.5 or 1.5 mg/kg body weight (BW), depending on the amount of forskolin added to 
the dough pellets. Every morning, the fish were fed with a small wheat flour dough 
containing the control, medium and high forskolin diets at 1% body weight for 30 
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min before normal feeding with the high fat diet. Afterwards, the same amount of 
high fat diet was fed to the fish at 4% body weight. One hour later, the uneaten diets 
were removed by siphon, dried and weighed for determination of FCR. The 
formulations of the high fat diet and wheat flour-dough particle are listed in Table 2. 
The water quality in all experimental tanks were relatively similar to those used 
during acclimation.  
 
2.3.2. Growth performance and feed efficiency  
At the end of eight-week trial, all fish were fasted for 12 hours, collected by 
using a scoop net and their individual final weights measured for determination of 
weight gain and FCR using the following formulae:  
Weight gain (WG, %) = [final weight – initial weight]  100 / initial weight  
Feed conversion ratio (FCR) = dry feed weight / wet weight gain.  
 
2.3.3. Serum biochemical analysis and hepatosomatic and mesenteric fat indices 
A sample of 20 fish from each treatment were anesthetized by using MS-222 
(25 mg/L) as described above for blood sampling. The blood was drawn from the 
caudal vein using 2 mL syringes (Klmedical, China). Blood samples were 
immediately centrifuged at 1000 rpm for 10 min at 4 
°
C, the serum was placed into 
polypropylene tubes. Serum TG and FFAs concentrations were determined by using 
specific commercial assay kits (Jiancheng Biotech CO., China).  
The remaining fish after blood sampling were dissected to obtain muscle, liver 
and adipose tissues. Each liver or adipose tissue was weighed to determine the 
hepatosomatic index (HSI) and mesenteric fat index (MFI) by using the following 
formulae: 
Hepatosomatic index (HSI, %) = wet liver weight  100 / wet body weight; 
Mesenteric fat index (MFI, %) = wet mesenteric fat weight  100 / wet body 
weight. 
 
2.3.4. Proximate analysis of whole fish and muscle, liver and adipose tissues  
A sample of six fish were collected randomly from each treatment and stored at 
-20 
°
C for whole body composition analysis. Whole body composition, muscle and 
liver tissues were analyzed according to the methods described by Bligh and Dyer 
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(1959) with some modifications. Each whole fish was dried at 70 
°
C to constant 
weight and then ground to powder. About 60 mg fish powder, muscle, liver or 
adipose tissues were homogenized in 5 mL chloroform/methanol (1:1, v/v) and 
stored at 4 
°
C for overnight after blending for 30 sec, followed by adding 1 mL 0.28 
mM KCl and blending for 30 sec. After centrifugation at 1200 rpm for 10 min, 
subnatant was imbibed and filtered through filter paper into pre-weighed glass tubes 
by Pasteur pipettes. Total lipid was quantified by gravimetry using a vacuum drying 
oven (DZH-6050, Jinghong, Ltd, Shanghai, China). The total protein of whole fish 
body was determined by a semi-automatic Kjeldahl System (FOSS, Sweden) after 
acid digestion.  
 
2.3.5. Histology analysis 
The liver and adipose tissues from three fish in each group were cut into 2-mm 
pieces and stored in paraformaldehyde. After dehydrated, the samples were 
embedded in paraffin and sliced into 4 μm-thick sections. Each section was stained 
with hematoxylin and eosin, examined microscopically and photographed on a 
Nikon Microscope ECLIPSE Ni (Nikon Corporation, Tokyo, Japan). The lipid 
droplet area was measured and calculated by Image J (LOCI, University of 
Wisconsin, U.S.A). 
 
2.3.6. Lipolysis and β-oxidation mRNA expression in liver and adipose tissues 
The liver and adipose tissue samples from 12 fish per treatment were used for 
molecular analyses as described previously in section 2.2.2 above. Before analysis, 
samples were collected and stored at -80 
°
C until the time for analyses. All the 
primers for the amplification of genes used in this study are listed in Table 1.  
 
2.4. Statistical analyses 
All results are presented as mean ± S.E.M. Data were tested for normality and 
homogeneity of variances using Shapiro-Wilk and Levene’s tests, respectively. The 
in vitro results were analyzed by independent-samples t-test to evaluate the 
significant difference (P < .05) and extremely difference (P < .01) for measured 
variables between the control and 50 µM forskolin cells. One – way analysis of 
variance (ANOVA) was used to detect the possible differences in measured 
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parameters among control and the different forskolin concentrations for the in vivo 
experiments. When differences were detected, Tukey’s post hoc test was performed 
to determine specific differences. All analyses were conducted using the SPSS 
Statistics version 23 software (IBM, USA). 
 
3. Results  
3.1. In vitro results  
3.1.1 Lipolysis in adipocytes and hepatocytes 
We determined the ability of forskolin to stimulate lipolysis by using APCs and 
HPCs (Fig. 1). The 50 µM forskolin stimulated lipolysis both in APCs and HPCs by 
increasing FFAs (Fig. 1A) and glycerol release (Fig. 1B; P < .05). However, the 50 
µM forskolin decreased TG content in the APCs cells but not in HPCs (Fig. 1C).  
 
3.1.2. Lipolysis and β-oxidation genes expression 
The mRNA expressions showed a similar tendency between APCs and HPCs 
(Fig. 2). The forskolin treatment up-regulated ATGL and PKAR I mRNA genes 
expression (P < .05; Fig. 2). However, forskolin doses did not affect the mRNA 
expression of HSL gene (P > .05). The forskolin treatment elevated the genes 
related to β-oxidation such as PPARα and CPT1 (P < .05) except FABP1 (P > .05; 
Fig. 2). These results indicate that, in the in vitro experiments, forskolin stimulated 
lipolysis in both APCs and HPCs by regulating lipases and β-oxidation genes. 
 
3.2. In vivo results 
3.2.1. Growth performance, feed efficiency and body indices  
The forskolin doses did not affect the WG of Nile tilapia compared to the 
control (P < .05). However, fish fed on 0.5 mg/kg forskolin had significantly lower 
FCR (by nearly 40%) compared to those fed on the control diet (P < .05; Fig. 3). 
When fish were fed with 1.5 mg/kg forskolin, the FCR was statistically comparable 
to the control and 0.5 mg/kg forskolin (P > .05). The HSI and MFI in fish fed the 
different forskolin doses were reduced significantly in comparison to the control (P 
< .05), but did not differ between the two doses (P > .05; Fig. 3).  
 
3.2.2. Body proximate composition, liver and muscle and serum biochemical indices 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
11 
 
The forskolin diets decreased significantly lipid in the whole fish and the liver 
compared to control (Fig. 4A and 4B; P < .05), but not in the muscle (Fig. 4C; 
P > .05). The fish fed on the forskolin doses decreased significantly the glycerol 
content in the serum compared to the control (P < .05; Fig. 4D). The FFAs content 
increased by two folds in the 1.5 mg/kg forskolin dose compared to the 0.5 mg/kg 
forskolin and the control (P < .05; Fig. 4E). The forskolin doses did not affect 
protein content in the whole fish and the liver among the different treatments 
(P > .05; Fig. 4F and 4G). 
 
3.2.3. Histology 
To determine whether forskolin could reduce fat accumulation in Nile tilapia, 
the liver and adipose tissues were sectioned, stained and photographed. The liver 
tissue sections for the fish fed on forskolin doses exhibited vacuolar degeneration 
and an increase in hepatic parenchyma (Fig. 5E and 5F). The fish fed on the 0.5 
mg/kg forskolin treatment decreased the lipid droplet area in adipose compared to 
control (P < .05; Fig. 5G). Similarly, the fish fed on forskolin doses decreased the 
lipid droplet area in the liver in a dose-dependent manner compared to control (P 
< .05; Fig. 5H).  
 
3.2.4. Lipolysis and β-oxidation mRNA expressions in liver and adipose tissues 
The forskolin treatment influenced significantly the expression of ATGL, HSL 
and monoacylglycerol lipase, MGL genes. In adipose, lipase genes were 
up-regulated by both forskolin doses (P < .05; Fig. 6A). However, in the liver tissue, 
the ATGL gene increased while the MGL gene was down-regulated (P < .05; Fig. 
6B). The PKAR I and PKAR II genes showed different tendencies between the 
adipose and liver tissues. The PKAC gene was up-regulated in both tissues (P < .05). 
The expressions of β-oxidation related genes such as PPARα, FABP1, CPT1 and 
acyl-CoA oxidase (ACO) were increased by four-fold in the liver of fish fed on 
forskolin compared with the control (P < .05). In the adipose, the 0.5 mg/kg 
forskolin dose up-regulated FABP1 and CPT1 expressions (P < .05), while no 
difference in expression was found between the 1.5 mg forskolin /kg treatment and 
the control (P > .05; Fig. 6A). The results on in vivo experiments show that similar 
to the results in vitro, oral administration of forskolin decreased lipid content, 
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glycerol content and influenced the mRNA of genes related to lipolysis and 
β-oxidation.  
 
4. Discussion 
Lipolysis is an important biochemical process, which breaks down TG into 
FFAs, for utilization by different body cells (Young and Zechner, 2013; Zechner et 
al., 2012). In mammals, ATGL, HSL and MGL are mainly involved in the lipolysis 
process from TG to diacylglycerols (Seamon et al.)  , DG to monoacylglycerols 
(MG), and MG to FFAs, respectively (Chanda et al., 2010; Jenkins et al., 2004; 
Vaughan et al., 1964; Villena et al., 2004; Zimmermann et al., 2004). Similar to 
mammals, the three lipases are regulated by the levels of lipids, FFAs, hormones 
and bioactive ingredients in fish such as grass crap (Ctenopharynogodon idella) (Ji 
et al., 2012), rainbow trout (Oncorhynchus mykiss) (Kittilson et al., 2011), Japanese 
flounder (Paralichthys olivaceus) (Khieokhajonkhet et al., 2014), large yellow 
croaker (Larimichthys crocea) (Wang et al., 2013) as well as Nile tilapia (Ning et al., 
2016; Ning et al., 2017; Tian et al., 2013). Although forskolin plays a positive role 
in reducing fat accumulation in mammals through PKA-dependent activation of 
HSL and ATGL (Belfrage et al., 1982; Bezaire et al., 2009), little is known about 
the effects of forskolin on fat metabolism in fish both in vivo and in vitro. In the 
present study, both doses of 0.5 and 1.5 mg/kg forskolin reduced fat accumulation in 
vivo by decreasing lipid contents in the whole fish and the liver. Moreover, the HSI 
and MFI in the fish fed on forskolin were also lower than those in the control. 
Furthermore, the histological observations confirmed vacuolar degeneration, 
hyperplasia of hepatic parenchyma and reduction of lipid droplet size in the adipose 
tissue of the fish fed on forskolin doses. The present study demonstrates that the 
forskolin can help to decrease fat accumulation in Nile tilapia fed on high fat diet. 
To the best of our knowledge, the present study was the first to show that 
forskolin can stimulate lipolysis in APCs and HPCs in fish. Although HSL gene 
expression was not increased significantly by forskolin in APCs and HPCs for the in 
vitro experiments, the dietary supplementation of forskolin up-regulated 
significantly HSL mRNA expression in the Nile tilapia adipose tissues in the in vivo 
experiments. Moreover, the adipose tissue seems to be more sensitive to forskolin 
than the liver tissue because ATGL, HSL and MGL mRNA expressions were all 
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increased in the adipose tissue but not in the liver tissue. This may be due to the fact 
that, the adipose rather than the liver is the main tissue for lipid deposition and 
lipolysis (Ahmadian et al., 2007). These results indicate that, similar to mammals, 
forskolin can stimulate lipolysis by up-regulating the mRNA expression of PKAR I, 
II and PKAC as well as the lipases genes such as ATGL, HSL and MGL.  
Presently, there is no evidence which shows toxicity of forskolin in animal 
trials. In a previous study, the root extract of Coleus forskohlii induced 
hepatotoxicity in mice by unidentified constituents in the plant rather than by the 
forskolin itself (Virgona et al., 2013). Similarly, in the present study, forskolin also 
did not affect fish weight gain and protein content, which are the important 
variables to evaluate fish growth and nutritional status. These results suggest, 
forskolin has little influence on Nile tilapia growth, although more studies are still 
needed to evaluate the health effects of forskolin on fish.  
Lipolysis and fatty acid oxidation are two important mechanisms involved in 
fat reduction. Over stimulation of lipolysis increases the level of FFAs in the serum 
and causes metabolic perturbation (Koutsari and Jensen, 2006). A large inflow of 
FFAs to the mitochondria may lead to mitochondrial membrane permeabilization 
and cell death (Engin, 2017). Lipotoxicity occurs due to unbalanced lipolysis 
(Bülow et al., 2017) or impaired β-oxidation (Haffar et al., 2015). Therefore, Langin 
(2006) suggested that the control of molecules that stimulate lipolysis and fatty acid 
(FA) oxidation release could be a useful approach to decrease fat accumulation. 
Forskolin seems to be an efficient supplement compared to other weight 
management compounds like L-carnitine and fenofibrate have been used, which 
showed different degrees of effectiveness in lipid metabolism. Using L-carnitine, Li 
et al. (2017) showed enhanced mitochondrial β-oxidation activities and decreased 
lipid in liver and muscle tissues of treated zebrafish. However, L-carnitine 
application showed no effects on lipid metabolism in some fish species like African 
catfish (Torreele et al., 1993), hybrid tilapia (Yang et al., 2009) and hybrid striped 
bass (Twibell and Brown, 2000) or even caused negative effects on lipid metabolism 
in red sea bream (Chatzifotis et al., 1995) and rainbow trout (Selcuk et al., 2010). 
By using fenofibrate, Ning et al. (2016) indicated increased PPARα mRNA 
expression and decreased hepatic TG in Nile tilapia. Their following work also 
showed decreased hepatic and plasma TG in Nile tilapia fed with on fat diet 
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supplemented with fenofibrate (Ning et al., 2017). However, these authors pointed 
out that dietary fenofibrate did not change mesenteric fat quantity and TG 
concentrations in muscle and adipose tissues.  
Interestingly in the present study, a significant increase in serum FFAs was also 
obtained when the fish were fed with 1.5 mg/kg forskolin in the in vivo experiments. 
However, considering the up-regulation of genes such as PPAR α, FABP-1, CPT-1 
and ACO, which are all related to fatty acid β-oxidation, forskolin is likely to 
increase lipolysis to stimulate fatty acid breakdown. Previous studies have also 
indicated that, forskolin can up-regulate both PPAR isoforms (α, β, γ) in salmon 
(Pavlikova et al., 2010) and increase FA β-oxidation in vitro and in vivo in mice 
(Gerhart-Hines et al., 2011). Therefore, forskolin modulates lipid metabolism in fish 
because the circulation of lipolysis-mediated FFAs has been identified as the ligand 
of PPARα (Narala et al., 2010; Pace et al., 2008) and the activation of PPARα also 
triggers FA β-oxidation (Leone et al., 1999; Storch and Thumser, 2000; Wakil and 
Abu-Elheiga, 2009). These results suggest that, forskolin supplementation can 
systemically increase the lipid catabolism pathways and efficiently reduce body 
lipid accumulation in cultured fish. 
 
5. Conclusion   
Forskolin stimulates Nile tilapia lipolysis by regulating PKA, lipases and FFAs 
oxidation related genes. Feeding Nile tilapia with forskolin at a dose of 0.5 or 1.5 
mg kg body weight per day reduce remarkably the fat accumulation and promote 
lipid catabolism. This study proposes the use of forskolin to reduce lipid 
accumulation in cultured fish. Future studies are needed to determine the safety 
level of forskolin in fish diets.  
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Figure captions：  
 
Fig. 1. Effect of forskolin stimulation on lipolysis in vitro Nile tilapia. 
(A) FFAs release, (B) glycerol release and (C) triglyceride content in adipocyte and 
hepatocyte treated with 50 μM forskolin. Values are mean ± S.E.M from four 
replicates with each replicate contents ~10
6
 cells. A single asterisk (*) or double 
asterisks (**) indicate significant different (P < .05) or extremely different (P < .01) 
among treatments.  
 
Fig. 2. The in vitro expression of lipolysis and β-oxidation genes in Nile tilapia after 
stimulation with forskolin. 
The mRNA relative expression of lipolysis and β-oxidation related genes in O. 
niloticus (A) adipocytes and (B) hepatocytes treated with 50 μM forskolin. Values are 
mean ± S.E.M from four replicates. A single asterisk (*) or double asterisks (**) are 
indicate significant different (P < .05) or extremely different (P < 0.01) among 
treatments. 
 
Fig. 3. Growth performance, feed efficiency and organ indices of Nile tilapia fed with 
forskolin for two weeks. 
(A) Weight gain, (B) feed conversion ratio, (C) hepatosomatic index and (D) 
mesenteric fat index of O. niloticus fed with 0.5 mg/kg body weight (BW) and 1.5 
mg/kg BW forskolin. Values are mean ± S.E.M for three replicates, each replicate 
containing twenty fish. A single asterisk (*) or double asterisks (**) indicate 
significant different (P <.05) or extremely different (P < .01) among treatments.  
Fig. 4. Fish body composition analysis of Nile tilapia fed on forskolin for two weeks. 
Total lipid of (A) whole fish, (B) liver tissue and (C) muscle, serum (D) glycerol 
content, (E) FFAs release, total protein of (F) whole fish and (G) muscle after feeding 
with 0.5 mg/kg BW and 1.5 mg/kg BW forskolin. Values are mean ± S.E.M for three 
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replicates each replicate containing six fish for whole body analysis and three 
replicates each replicate containing twenty fish for tissues and serum samples. A 
single asterisk (*) or double asterisks (**) indicate significant different (P < .05) or 
extremely different (P < .01) among treatments.  
 
Fig. 5. Adipose and liver tissue histology of Nile tilapia fed with forskolin. 
Adipose tissue paraffin sections of O. niloticus fed with wheat flour containing (A) 
DMSO, (B) 0.5 mg/kg BW and (C) 1.5mg/kg BW forskolin. The liver tissue paraffin 
sections of O. niloticus with same treatment are shown in Fig. 5 (D), (E) and (F). Fig. 
5 (G) and (H) show the percentage of lipid droplet area of the section area (24162 μm2) 
in adipose and liver tissue, respectively.  
 
Fig. 6. The in vivo mRNA expression of lipolysis and β-oxidation genes of Nile 
tilapia fed with forskolin. 
The mRNA relative expression of lipolysis and β-oxidation related genes in O. 
niloticus (A) adipose and (B) liver tissues fed with 0.5 mg/kg BW and 1.5 mg/kg BW 
forskolin. Values are mean ± S.E.M for twelve fish. A single asterisk (*) or double 
asterisks (**) are significantly different (P < 0.05) or extremely different (P < 0.01) 
among treatments. 
 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
24 
 
List of tables 
 
Table 1 
Primer pair sequences and product size of the genes used for real-time PCR (qPCR) 
Gene Position 5’-3’ primer sequence Product 
size 
(bp) 
GenBank NO. 
ATGL Forward AAAACGTCCTGGTGACCCAGT 104 XM_003440346 
 Reverse TAGGAGGAATGATGCCACAGTACA   
HSL Forward AACCTGGATGTCCATTTCTGGAAG 102 FJ601660 
 Reverse TCGGTTTACCTTGACTTGAGTGGA   
MGL Forward ACATCGTCAACGCAGACGGATT 105 XM_005478351.1 
 Reverse CACAATGTTCCCCAGCTCCAT   
PKAR I Forward AGTTCCCGTTCAGACTCTCGTGAT 117 XM_003438740.4 
 Reverse GGCGGCATCCTCCTCTGTGTAA   
PKAR 
II 
Forward CCTGCCGAGACATCCTACTCTTCA 99 XM_005478353.3 
 Reverse CGTGCTCCTGAGGCTTAACAATCA   
PKAC Forward TGGGCACGGGCTCATTTGGT 99 XM_003449976.4 
 Reverse GCTTGACCACCTTCTGCTTGTTGA   
PPARα Forward CTGATAAAGCTTCGGGCTTCCA 106 KF871430 
 Reverse CGCTCACACTTATCATACTCCAGCT   
FABP1 Forward ACTATCGGACAGGAGGCTGAACTA 98 XM_003446092 
 Reverse TTCTTCAGGGTGGTCTTCAGCTT   
CPT1 Forward TTTCCAGGCCTCCTTACCCA 102 XM_003440552 
 Reverse TTGTACTGCTCATTGTCCAGCAGA   
ACO Forward AGTCCCACTGTGAGCTCCATCAA 108 KF918710 
 Reverse CAGACCATGGCAGTTTCCAAGA   
EF1α Forward ATCAAGAAGATCGGCTACAACCCT 109 KJ123689 
 Reverse ATCCCTTGAACCAGCTCATCTTGT   
ATGL, adipose triglyceride lipase. HSL, hormone-sensitive lipase. MGL, 
monoacylglycerol lipase. PKARI, protein kinase cAMP-dependent type I regulatory 
subunit alpha. PKARII, protein kinase cAMP-dependent type II-alpha regulatory 
subunit. PKAC, protein kinase cAMP-activated catalytic subunit. PPARα, peroxisome 
proliferator activated receptor alpha. FABP1, fatty acid binding protein 1. CPT1, 
carnitine O-palmitoyltransferase 1. ACO, acyl-CoA oxidase. EF1α, elongation factor 
1α. 
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Table 2 
Feed formulation (g/kg) and proximate composition of high fat diet (HFD) fed to 
Oreochromis niloticus 
 
Ingredients  
Casein 304 
Gelatin  76 
Soybean oil  75 
Flaxseed oil  75 
Corn starch 300 
Vitamin pre-mix
a
  14.4 
Mineral pre-mix
b
  22.4 
Carboxymethyl cellulose  50 
Cellulose  68.8 
Choline chloride   5 
Butylated hydroxytoluene   0.25 
Total 1000 
Analyzed proximate composition (%)  
Moisture 10.6 
Total protein 
Total lipid 
36.27 
15.31 
Ash  3.8 
Wheat flour component (100 g)  
Protein (g) 12.2 
Lipid (g)  1.5 
Carbohydrate (g) 70 
a
 Vitamin premix (mg or IU/kg): 500,000 I.U. (international units) Vitamin A, 50,000 I.U. 
Vitamin D3, 2500 mg Vitamin E, 1000 mg VitaminK3, 5000 mg Vitamin B1, 5000 mg Vitamin 
B2, 5000 mg Vitamin B6, 5000 μg Vitamin B12, 25,000 mg Inositol, 10,000 mg Pantothenic acid, 
100,000 mg Choline, 25,000 mg Niacin, 1000 mg Folic acid, 250 mg Biotin, 10,000 mg Vitamin 
C. 
b
Mineral premix, (g/kg): 314.0 g CaCO3; 469.3 KH2PO4; 147.4 g MgSO4·7H2O; 49.8 g NaCl; 
10.9 g Fe (II) gluconate; 3.12 g MnSO4·H2O; 4.67 g ZnSO4·7H2O; 0.62 g CuSO4·5H2O; 0.16 g 
KJ; 0.08 g CoCl2·6H2O; 0.06 g NH4 molybdate; 0.02 g NaSeO3.  
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Supplementary 
Fig. 1S. Effect of different doses of forskolin stimulation on lipolysis in vitro Nile 
tilapia. 
FFAs release in adipocyte and hepatocyte treated with 50 and 100 μM forskolin. 
Values are mean ± S.E.M from four replicates with each replicate contents ~10
6
 cells. 
A single asterisk (*) or double asterisks (**) indicate significant different (P < .05) or 
extremely different (P < .01) among treatments. 
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1. Forskolin supplementation in the diet reduced fat accumulation in Nile tilapia. 
2. Lipolysis and β-oxidation in adipocytes and hepatocytes were stimulated by 50 
μM forskolin in vitro.  
3. The oral doses of 0.5 and 1.5 mg/kg forskolin reduced fat in the liver and whole 
fish.  
4. Forskolin up-regulated the expression of genes relevant to lipolysis and 
β-oxidation. 
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